Organization
Ossium Health
3 clinical trials
Clinical trial
A Phase I Safety Study of Single Dose Allogeneic Bone Marrow Derived MSCs for Steroid Refractory Acute Graft vs. Host DiseaseStatus: Withdrawn, Estimated PCD: 2024-06-10
Clinical trial
A Phase I Safety Study of Allogeneic Bone Marrow Derived MSCs for Refractory Perianal Fistulizing Crohn's DiseaseStatus: Withdrawn, Estimated PCD: 2024-04-01
Clinical trial
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers That Progressed on PD-1/PD-L1 InhibitorsStatus: Recruiting, Estimated PCD: 2026-06-30